Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase
about
Effects of tempol and redox-cycling nitroxides in models of oxidative stress.Influence of gestational salt restriction in fetal growth and in development of diseases in adulthoodInterplay between oxidant species and energy metabolismMechanism of Ang II involvement in activation of NF-κB through phosphorylation of p65 during agingAngiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptorAttenuation of renal excretory responses to ANG II during inhibition of superoxide dismutase in anesthetized rats.Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.Activation of systemic, but not local, renin-angiotensin system is associated with upregulation of TNF-α during prolonged fasting in northern elephant seal pups.Renin Angiotensin system-modifying therapies are associated with improved pulmonary health.The renin angiotensin system and the metabolic syndromeThe effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathwaysNicotine signaling and progression of chronic kidney disease in smokers.Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression.Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions.Oxidative stress and the etiology of insulin resistance and type 2 diabetes.Inhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney.Urotensin II inhibits skeletal muscle glucose transport signaling pathways via the NADPH oxidase pathway.Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexiaHypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment.Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB.Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin IIUnbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathyAndrographolide derivative AL-1 improves insulin resistance through down-regulation of NF-κB signalling pathway.Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance.The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndromeKlotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway.Mechanisms of Cachexia in Chronic Disease StatesLoss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.The renin angiotensin aldosterone system and insulin resistance in humans.Vascular-targeted therapies for Duchenne muscular dystrophyLate-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle.Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.Prevention of diabetes in hypertensive patients: results and implications from the VALUE trialRole of renin-angiotensin system in adipose tissue dysfunction.The renin-angiotensin system: a link between obesity, inflammation and insulin resistance.Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms.The renin-angiotensin system in the pathophysiology of type 2 diabetes.Clinical biomarkers in metabolic syndrome.Modulation of the action of insulin by angiotensin-(1-7).
P2860
Q24595411-C0B60BC1-7840-49B5-B44C-B6ED9AE9EE76Q28080277-4D35D466-15CB-4254-82B5-E73A148FF9DFQ28383905-A664C3C7-DA0C-472F-8868-4B695EB0C3CEQ28578917-2A943483-7C7F-415E-8B48-44B9EFF8930FQ30393746-707471E6-303A-49DA-AFAF-73C17EE0A86BQ30893366-82570195-A020-415D-AA5B-188EEB6444A5Q33552248-F5EF5764-05C6-4383-ADA0-1F1F2F2E6CDDQ33817992-1AA61591-B4E0-4A57-8583-D5D75A87E8EBQ33846532-CA3BCC12-F17D-4D23-BC75-61B816E1E5EDQ33915412-842D8E91-7F70-49AA-8A05-C01991664EE5Q34144560-AE6AD3D0-B1A8-4CA8-B090-4FB937D94B51Q34360219-A4152EC3-706C-4A75-BDF6-21CDB1FE42F7Q34555267-C59835BF-4117-46F8-8BA9-AB6001B04D7EQ34571546-A184A1FF-A101-4429-B28D-B2C9AAA7FCEDQ34768229-CCED3486-901A-4D49-B8E5-D51B56421FC7Q35013600-69A65659-379D-4597-8357-7EEEFDDFAA5FQ35014906-F2D3504F-02F0-42AE-80EE-08FCB9C8C06DQ35569439-80C598E7-55BA-41AA-AFB2-3CEDE5F6D1B1Q35575433-24202C92-4E33-4DB7-B21F-B819B2D04A9CQ35576849-BC528A7F-AF17-48A0-BE6D-BA2C6660D897Q35636863-E0F84D0B-8D2C-42D7-9193-A197042819D9Q35667361-9E9FAACD-239D-4A26-80DF-5DED7134F64DQ35693024-A325E1D4-D18C-45DF-A5FA-17532DA5D44FQ35736381-A61059DD-CD78-471D-959D-21D34A0B31E9Q35850133-C62BBB70-DE70-41E1-8D26-16AF81110E7FQ35928417-19CAAF14-566E-4C69-97B7-65B31629570CQ36103986-36A89E8E-FD5E-4242-AD78-303524A786BAQ36477252-D4336427-03CD-4A3C-B1FB-C541A66C7F78Q36550987-A7C10A88-D3D5-4683-BDD5-C7A7AA088C12Q36835180-C4CC5C0D-C643-4759-82FA-877FD3390B6BQ36993333-34989C7E-1283-4B58-9955-42550061A89CQ37038026-4E77097A-4FC5-48DD-9B87-7445582A9CA6Q37063375-00FA9397-3909-4546-B19C-3BD38F643C12Q37202131-F373E375-E38A-48C9-92C4-DAF8933392B9Q37466234-F22C5B8F-547B-483E-B33F-412AF3419665Q37950397-3AAD008E-9654-4B22-A206-E65DC3D447F6Q37973874-A05B8AB8-B3FC-40D7-B1E8-95C8D6720B14Q38044215-5946D3AA-5D15-4421-8CDF-B8DA21C25B5FQ38171244-7D6A8159-D0BD-4AB0-8185-D00EBF370155Q38180800-57B768DD-CB08-490C-8D57-4590331EBF51
P2860
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase
description
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
scientific journal article
@en
vedecký článok (publikovaný 2008/02/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/02/01)
@nl
наукова стаття, опублікована в лютому 2008
@uk
مقالة علمية (نشرت في فبراير 2008)
@ar
name
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@ast
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@en
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@nl
type
label
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@ast
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@en
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@nl
prefLabel
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@ast
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@en
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@nl
P2093
P2860
P1476
Angiotensin II-induced skeleta ...... B activation via NADPH oxidase
@en
P2093
Carlos M. Ferrario
Craig S. Stump
James R. Sowers
Suzanne E. Clark
Yongzhong Wei
P2860
P304
P356
10.1152/AJPENDO.00456.2007
P577
2008-02-01T00:00:00Z